• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞和树突状细胞在清除凋亡细胞过程中使用不同的Axl/Mertk/Tyro3受体。

Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.

作者信息

Seitz Heather M, Camenisch Todd D, Lemke Greg, Earp H Shelton, Matsushima Glenn K

机构信息

Department of Microbiology and Immunology, University of North Carolina-Chapel Hill, Chapel Hill, NC 27599, USA.

出版信息

J Immunol. 2007 May 1;178(9):5635-42. doi: 10.4049/jimmunol.178.9.5635.

DOI:10.4049/jimmunol.178.9.5635
PMID:17442946
Abstract

The clearance of apoptotic cells is important for regulating tissue homeostasis, inflammation, and autoimmune responses. The absence of receptor tyrosine kinases (Axl, Mertk, and Tyro3) results in widespread accumulation of apoptotic cells and autoantibody production in mice. In this report, we examine the function of the three family members in apoptotic cell clearance by different phagocytic cell types. Mertk elimination nearly abolished macrophage apoptotic cell phagocytosis; elimination of Axl, Tyro3, or both, reduced macrophage phagocytosis by approximately half, indicating that these also play a role. In contrast, apoptotic cell clearance in splenic and bone marrow-derived dendritic cells (DCs) is prolonged compared with macrophages and relied primarily on Axl and Tyro3. The slower ingestion may be due to lower DC expression of Axl and Tyro3 or absence of GAS6 expression, a known ligand for this receptor family. In vivo, phagocytosis of apoptotic material by retinal epithelial cells required Mertk. Unlike macrophages, there did not appear to be any role for Axl or Tyro3 in retinal homeostasis. Likewise, clearance of apoptotic thymocytes in vivo was dramatically reduced in mertk(kd) mice, but was normal in axl/tyro3(-/-) mice. Thus, cell and organ type specificity is clearly delineated, with DCs relying on Axl and Tyro3, retina and thymus requiring Mertk, and macrophages exhibiting an interaction that involves all three family members. Surprisingly, in macrophages, tyrosine phosphorylation of Mertk in response to apoptotic cells is markedly diminished from axl/tyro3(-/-) mice, suggesting that the interactions of these receptors by heterodimerization may be important in some cells.

摘要

凋亡细胞的清除对于调节组织稳态、炎症和自身免疫反应至关重要。缺乏受体酪氨酸激酶(Axl、Mertk和Tyro3)会导致小鼠体内凋亡细胞广泛积累和自身抗体产生。在本报告中,我们研究了这三个家族成员在不同吞噬细胞类型清除凋亡细胞中的功能。消除Mertk几乎完全消除了巨噬细胞对凋亡细胞的吞噬作用;消除Axl、Tyro3或两者,可使巨噬细胞吞噬作用降低约一半,表明它们也发挥作用。相比之下,脾脏和骨髓来源的树突状细胞(DCs)清除凋亡细胞的时间比巨噬细胞延长,且主要依赖Axl和Tyro3。摄取较慢可能是由于DCs中Axl和Tyro3的表达较低或缺乏该受体家族的已知配体GAS6的表达。在体内,视网膜上皮细胞对凋亡物质的吞噬需要Mertk。与巨噬细胞不同,Axl或Tyro3在视网膜稳态中似乎没有任何作用。同样,mertk(kd)小鼠体内凋亡胸腺细胞的清除显著减少,但axl/tyro3(-/-)小鼠体内清除正常。因此,细胞和器官类型的特异性清晰可辨,DCs依赖Axl和Tyro3,视网膜和胸腺需要Mertk,而巨噬细胞则表现出涉及所有三个家族成员的相互作用。令人惊讶的是,在巨噬细胞中,axl/tyro3(-/-)小鼠对凋亡细胞反应时Mertk的酪氨酸磷酸化明显减少,这表明这些受体通过异二聚化的相互作用在某些细胞中可能很重要。

相似文献

1
Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.巨噬细胞和树突状细胞在清除凋亡细胞过程中使用不同的Axl/Mertk/Tyro3受体。
J Immunol. 2007 May 1;178(9):5635-42. doi: 10.4049/jimmunol.178.9.5635.
2
Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation.产后乳腺中上皮细胞定向的胞葬作用对于组织稳态和未来的泌乳是必要的。
BMC Dev Biol. 2010 Dec 30;10:122. doi: 10.1186/1471-213X-10-122.
3
Axl and MerTK receptor tyrosine kinases maintain human macrophage efferocytic capacity in the presence of viral triggers.Axl 和 MerTK 受体酪氨酸激酶在病毒触发存在的情况下维持人类巨噬细胞的吞噬能力。
Eur J Immunol. 2018 May;48(5):855-860. doi: 10.1002/eji.201747283. Epub 2018 Feb 22.
4
Tyro3, Axl, and Mertk receptors differentially participate in platelet activation and thrombus formation.酪氨酸激酶受体 Tyro3、Axl 和 Mer 受体激酶(Mertk)受体在血小板激活和血栓形成中发挥不同的作用。
Cell Commun Signal. 2018 Dec 12;16(1):98. doi: 10.1186/s12964-018-0308-0.
5
Receptor tyrosine kinases Tyro3, Axl, and Mertk differentially contribute to antibody-induced arthritis.受体酪氨酸激酶 Tyro3、Axl 和 Mertk 对抗体诱导的关节炎有不同的作用。
Cell Commun Signal. 2023 Aug 3;21(1):195. doi: 10.1186/s12964-023-01133-0.
6
Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction.人巨噬细胞通过 M2c 极化和 MerTK 诱导来有效清除早期凋亡细胞。
J Immunol. 2012 Oct 1;189(7):3508-20. doi: 10.4049/jimmunol.1200662. Epub 2012 Aug 31.
7
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.TAM 家族受体激酶抑制逆转 MDSC 介导的抑制作用,并增强黑色素瘤的抗 PD-1 治疗。
Cancer Immunol Res. 2019 Oct;7(10):1672-1686. doi: 10.1158/2326-6066.CIR-19-0008. Epub 2019 Aug 26.
8
Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.MERTK受体酪氨酸激酶在上皮癌细胞中的过表达以功能获得的能力驱动了噬菌作用。
J Biol Chem. 2014 Sep 12;289(37):25737-49. doi: 10.1074/jbc.M114.570838. Epub 2014 Jul 29.
9
Retinal self-antigen induces a predominantly Th1 effector response in Axl and Mertk double-knockout mice.视网膜自身抗原在 Axl 和 Mertk 双敲除小鼠中诱导以 Th1 效应子反应为主。
J Immunol. 2011 Oct 15;187(8):4178-86. doi: 10.4049/jimmunol.1101201. Epub 2011 Sep 14.
10
TAM receptors are dispensable in the phagocytosis and killing of bacteria.酪氨酸激酶受体在细菌的吞噬和杀伤过程中并非必需。
Cell Immunol. 2009;259(2):128-34. doi: 10.1016/j.cellimm.2009.06.006. Epub 2009 Jun 21.

引用本文的文献

1
Engineering Efferocytosis for Bone Regeneration.用于骨再生的工程化胞葬作用
Macromol Biosci. 2025 Jul 4:e00094. doi: 10.1002/mabi.202500094.
2
Clinical significance of TAM receptor in the minor salivary glands of patients with Sjögren's disease.TAM受体在干燥综合征患者小唾液腺中的临床意义。
Sci Rep. 2025 Jul 2;15(1):23065. doi: 10.1038/s41598-025-08086-z.
3
Profound phenotypic deficiencies in mature blood and bone marrow progenitor dendritic cells in chronic lymphocytic leukemia patients.慢性淋巴细胞白血病患者成熟血液及骨髓祖细胞来源的树突状细胞存在显著的表型缺陷。
Leukemia. 2025 Jun 26. doi: 10.1038/s41375-025-02579-6.
4
Discovery of Novel TYRO3/MERTK Dual Inhibitors.新型TYRO3/MERTK双重抑制剂的发现
J Med Chem. 2025 Apr 24;68(8):8455-8470. doi: 10.1021/acs.jmedchem.5c00009. Epub 2025 Apr 11.
5
Exploiting structural variability in the kinase back-pocket to modulate polypharmacology of TAM inhibitors.利用激酶后口袋中的结构变异性来调节TAM抑制剂的多药理学特性。
Eur J Med Chem. 2025 Jun 5;290:117561. doi: 10.1016/j.ejmech.2025.117561. Epub 2025 Mar 28.
6
Navigating TAM receptor dynamics in tumour immunotherapy.探索肿瘤免疫治疗中的TAM受体动力学
Cancer Immunol Immunother. 2025 Mar 15;74(5):146. doi: 10.1007/s00262-024-03879-z.
7
UNC9426, a Potent and Orally Bioavailable TYRO3-Specific Inhibitor.UNC9426,一种强效且口服生物可利用的TYRO3特异性抑制剂。
J Med Chem. 2025 Mar 27;68(6):6665-6682. doi: 10.1021/acs.jmedchem.5c00048. Epub 2025 Mar 11.
8
Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?自身免疫性疾病和癌症中TAM受体的蛋白水解作用:它向我们传达了什么信息?
Cell Death Dis. 2025 Mar 5;16(1):155. doi: 10.1038/s41419-025-07480-9.
9
Early-age efferocytosis directs macrophage arachidonic acid metabolism for tissue regeneration.早期的胞葬作用引导巨噬细胞花生四烯酸代谢以促进组织再生。
Immunity. 2025 Feb 11;58(2):344-361.e7. doi: 10.1016/j.immuni.2024.11.018.
10
AXL: shapers of tumor progression and immunosuppressive microenvironments.AXL:肿瘤进展和免疫抑制微环境的塑造者
Mol Cancer. 2025 Jan 11;24(1):11. doi: 10.1186/s12943-024-02210-9.